AstraZeneca, FibroGen’s roxadustat hits snag at FDA, but analysts figure an approval’s still on its way December 21, 2020 Auto Bot News 0 AstraZeneca, FibroGen’s roxadustat hits snag at FDA, but analysts figure an approval’s still on its way esagonowsky Mon, 12/21/2020 – 09:33
